Home > Insider Trading > Biocryst Pharmaceuticals Inc

Biocryst Pharmaceuticals Inc (BCRX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2024 Earnings Call Transcript

Operator: Good day and Welcome to the BioCryst Third Quarter 2024 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded.

Keep Reading →

November 5th, 2024 - News Transcripts

Piper Sandler's Top Technical Stock Picks: 20 Best Stocks

The start of October has seen another wild swing for markets. September's second half saw Wall Street rejoice as the Federal Reserve delivered its highly anticipated interest rate cut.

Keep Reading →

October 8th, 2024 - News

10 Best Biotech Stocks To Buy Under $20

The biotechnology industry is experiencing rapid growth, driven by increasing demand for innovative treatments, technological advancements, and government support.

Keep Reading →

October 6th, 2024 - Hedge Funds News

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2024 Earnings Call Transcript

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2024 Earnings Call Transcript August 5, 2024BioCryst Pharmaceuticals, Inc. beats earnings expectations.

Keep Reading →

August 6th, 2024 - News Transcripts

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript

BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $-0.23.

Keep Reading →

May 7th, 2024 - News Transcripts

12 Best Depressed Stocks To Buy in 2024

JPMorgan Chief Jamie Dimon, in his latest letter to shareholders, has warned that the real odds of soft landing a quite low when compared to market expectations.

Keep Reading →

April 10th, 2024 - Hedge Funds News

13 Best Biotech Stocks To Buy Under $20

In this article, we're going to take a look at 13 best biotech stocks to buy under $20.

Keep Reading →

March 13th, 2024 - News

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript

BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.28 EPS, expectations were $-0.24. BioCryst Pharmaceuticals, Inc.

Keep Reading →

February 28th, 2024 - News Transcripts

5 Best Medical Stocks to Buy Under $10

In this article, we will take a look at the 5 best medical stocks to buy under $10.

Keep Reading →

February 27th, 2024 - Hedge Funds News

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2023 Earnings Call Transcript

Operator: Good morning and welcome to the BioCryst Pharmaceuticals Third Quarter 2023 Earnings Call. [Operator Instructions] Please note, this event is being recorded.

Keep Reading →

November 3rd, 2023 - News Transcripts